As of 2026-03-23, the Relative Valuation of Atossa Therapeutics Inc (ATOS) is (70.81) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.33 USD, the upside of Atossa Therapeutics Inc based on Relative Valuation is -1428.4%.
The range of the Relative Valuation is (64.22) - (74.45) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.3x - 22.6x | 20.0x |
| Forward P/E multiples | 17.5x - 21.2x | 20.4x |
| Fair Price | (64.22) - (74.45) | (70.81) |
| Upside | -1304.8% - -1496.8% | -1428.4% |
| Date | P/E |
| 2026-03-18 | -1.46 |
| 2026-03-17 | -1.57 |
| 2026-03-16 | -1.42 |
| 2026-03-13 | -1.43 |
| 2026-03-12 | -1.44 |
| 2026-03-11 | -1.36 |
| 2026-03-10 | -1.36 |
| 2026-03-09 | -1.30 |
| 2026-03-06 | -1.29 |
| 2026-03-05 | -1.34 |
| 2026-03-04 | -1.40 |
| 2026-03-03 | -1.35 |
| 2026-03-02 | -1.28 |
| 2026-02-27 | -1.26 |
| 2026-02-26 | -1.28 |
| 2026-02-25 | -1.22 |
| 2026-02-24 | -1.20 |
| 2026-02-23 | -1.13 |
| 2026-02-20 | -1.20 |
| 2026-02-19 | -1.26 |
| 2026-02-18 | -1.24 |
| 2026-02-17 | -1.18 |
| 2026-02-13 | -1.20 |
| 2026-02-12 | -1.12 |
| 2026-02-11 | -1.16 |
| 2026-02-10 | -1.38 |
| 2026-02-09 | -1.42 |
| 2026-02-06 | -1.52 |
| 2026-02-05 | -1.52 |
| 2026-02-04 | -1.51 |
| 2026-02-03 | -1.58 |
| 2026-02-02 | -1.59 |
| 2026-01-30 | -2.42 |
| 2026-01-29 | -2.57 |
| 2026-01-28 | -2.64 |
| 2026-01-27 | -2.93 |
| 2026-01-26 | -2.93 |
| 2026-01-23 | -2.75 |
| 2026-01-22 | -2.80 |
| 2026-01-21 | -2.58 |
| 2026-01-20 | -2.58 |
| 2026-01-16 | -2.63 |
| 2026-01-15 | -2.48 |
| 2026-01-14 | -2.58 |
| 2026-01-13 | -2.72 |
| 2026-01-12 | -2.80 |
| 2026-01-09 | -2.76 |
| 2026-01-08 | -2.79 |
| 2026-01-07 | -2.85 |
| 2026-01-06 | -2.83 |